These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 3137798

  • 21. [Role of a "bystander" concealed accessory pathway in the response to verapamil and flecainide treatment in a patient with nodal reentry tachycardia].
    Matteucci C, Busi G.
    G Ital Cardiol; 1996 Apr; 26(4):419-25. PubMed ID: 8707026
    [Abstract] [Full Text] [Related]

  • 22. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
    Gambhir DS, Bhargava M, Nair M, Arora R, Khalilullah M.
    Indian Heart J; 1996 Apr; 48(2):133-7. PubMed ID: 8682552
    [Abstract] [Full Text] [Related]

  • 23. Electrophysiologic and antiarrhythmic effects of oral encainide in patients with atrioventricular nodal reentry or nodoventricular reentry.
    Miles WM, Chang MS, Heger JJ, Rinkenberger RL, Zipes DP, Prystowsky EN.
    Am Heart J; 1987 Jul; 114(1 Pt 1):26-33. PubMed ID: 3111237
    [Abstract] [Full Text] [Related]

  • 24. Double-blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardia.
    Hammill SC, McLaran CJ, Wood DL, Osborn MJ, Gersh BJ, Holmes DR.
    J Am Coll Cardiol; 1987 Jun; 9(6):1364-8. PubMed ID: 3584724
    [Abstract] [Full Text] [Related]

  • 25. Nadolol and supraventricular tachycardia: an electrophysiologic study.
    Chang MS, Sung RJ, Tai TY, Lin SL, Liu PH, Chiang BN.
    J Am Coll Cardiol; 1983 Nov; 2(5):894-903. PubMed ID: 6138376
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Safety and efficacy of oral flecainide therapy in patients with atrioventricular re-entrant tachycardia.
    Cockrell JL, Scheinman MM, Titus C, Helmy I, Langberg JJ, Lee MA, Griffin JC.
    Ann Intern Med; 1991 Feb 01; 114(3):189-94. PubMed ID: 1898629
    [Abstract] [Full Text] [Related]

  • 29. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
    Kühlkamp V, Ickrath O, Schmid F, Mayer F, Haasis R, Seipel L.
    Z Kardiol; 1989 Oct 01; 78(10):640-6. PubMed ID: 2686251
    [Abstract] [Full Text] [Related]

  • 30. Long-term follow-up of patients with inducible supraventricular tachycardia treated with flecainide or propafenone: therapy guided by transesophageal electropharmacologic testing.
    Furlanello F, Guarnerio M, Inama G, Vergara G, Del Greco M, Bertoldi A, Dallago M.
    Am J Cardiol; 1992 Aug 20; 70(5):19A-25A. PubMed ID: 1509994
    [Abstract] [Full Text] [Related]

  • 31. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia.
    Lai WT, Voon WC, Yen HW, Chang JS, Sheu SH, Hwang YS, Chiu HF.
    Am J Cardiol; 1993 Feb 15; 71(5):405-8. PubMed ID: 8430627
    [Abstract] [Full Text] [Related]

  • 32. [Use of digoxin in patients with paroxysmal supraventricular tachycardia].
    Smetnev AS, Titov VN, Shevchenko NM, Gurevich EM.
    Kardiologiia; 1989 Apr 15; 29(4):61-4. PubMed ID: 2666709
    [Abstract] [Full Text] [Related]

  • 33. Role of intravenous isoproterenol in the electrophysiologic induction of atrioventricular node reentrant tachycardia in patients with dual atrioventricular node pathways.
    Huycke EC, Lai WT, Nguyen NX, Keung EC, Sung RJ.
    Am J Cardiol; 1989 Nov 15; 64(18):1131-7. PubMed ID: 2479251
    [Abstract] [Full Text] [Related]

  • 34. Clinical usefulness of flecainide acetate in the treatment of paroxysmal supraventricular arrhythmias.
    Camm AJ, Hellestrand KJ, Nathan AW, Bexton RS.
    Drugs; 1985 Nov 15; 29 Suppl 4():7-13. PubMed ID: 4006783
    [Abstract] [Full Text] [Related]

  • 35. [Cibenzoline: electrophysiologic effects of a new class I anti-arrhythmia agents in supraventricular tachycardia].
    Pfitzner P, Manz M, Schütz R, Lüderitz B.
    Z Kardiol; 1989 Oct 15; 78(10):654-60. PubMed ID: 2686252
    [Abstract] [Full Text] [Related]

  • 36. [Wolff-Parkinson-White syndrome with orthodromic supraventricular tachycardia associated with a "hyper-conductor" atrio-ventricular node. A therapeutic challenge].
    Hernández González D, Iturralde Torres P, Romero L, Colín L, Villarreal A, González Hermosillo JA.
    Arch Inst Cardiol Mex; 1990 Oct 15; 60(2):175-81. PubMed ID: 2378538
    [Abstract] [Full Text] [Related]

  • 37. Paroxysmal nonreentrant supraventricular tachycardia due to simultaneous fast and slow pathway conduction in dual atrioventricular node pathways.
    Kim SS, Lal R, Ruffy R.
    J Am Coll Cardiol; 1987 Aug 15; 10(2):456-61. PubMed ID: 3110241
    [Abstract] [Full Text] [Related]

  • 38. Dual AV nodal paths leading to AV nodal reentrant tachycardia.
    Krishel S, Geninatti M.
    J Emerg Med; 1992 Aug 15; 10(3):303-7. PubMed ID: 1624743
    [Abstract] [Full Text] [Related]

  • 39. [Slow and fast AV nodal pathways in tachycardia complicating Wolff-Parkinson-White syndrome: report of a case].
    Vitale P, Santangelo L, Vitale N, Nave C, Civitillo UF, Curcio N, Iacono A.
    Cardiologia; 1992 Nov 15; 37(11):775-80. PubMed ID: 1298547
    [Abstract] [Full Text] [Related]

  • 40. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia.
    Manz M, Steinbeck G, Lüderitz B.
    Am J Cardiol; 1985 Oct 01; 56(10):593-7. PubMed ID: 4050693
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.